CRID obtained the Silver status

After five years of dedicated work, professionalism, and commitment, CRID has achieved a significant milestone by being certified and awarded “Silver Status” in compliance with the ARS 1651:2018 Good Financial Grant Practice-Requirements. This prestigious recognition signifies CRID’s ability to efficiently manage grants of substantial amounts. It not only enhances the organization’s visibility to funders but…

Master dissertation: Mbakam Bertrand’s study focused on “UDP-Glycosyltransferase Genes in the Primary Malaria Vector Anopheles funestus and Their Potential Contribution to Pyrethroid Resistance”

On Thursday, June 8th, 2023, Mr. Mbakam Leuze Patrick Bertrand, a Laboratory Technician at CRID, successfully defended his Master’s dissertation in Biochemistry at the University of Yaoundé I on the topic: “(Uridine-Diphosphate) UDP-Glycosyltransferase Genes in the Primary Malaria Vector, Anopheles funestus, and: Potential Contribution to Pyrethroid Resistance”. The aim of this study was to determine…

PUBLICATION: Anopheles funestus populations across Africa Are Broadly Susceptible to Neonicotinoids but with Signals of Possible Cross-Resistance from the GSTe2 Gene By Tatiane ASSATSE & al

Evaluating the susceptibility of malaria vectors to the new WHO-recommended products is a key step before large-scale deployment. In the present study, Tatiane ASSATSE and collaborators mapped the susceptibility profile of one of the major malaria vectors, Anopheles funestus, to neonicotinoids insecticides across Africa and they established the diagnostic doses of acetamiprid and imidacloprid (other neonicotinoids insecticides)…